(201 days)
The Microlife Digital Infrared Ear Thermometer, Model IRIDNI (IR210) device is an electronic clinical thermometer using an infrared sensor to detect body temperature from the auditory canal in the neonatal, pediation used in the home setting.
The Microlife Digital Infrared Ear Thermometer, Model IR1DN1 (IR210) is an electronic thermometer using an infrared sensor (thermopile) to detect body temperature from the auditory canal. Its operation is based on measuring the natural thermal radiation emanating from the tympanic membrane and the adjacent surfaces.
The provided text describes the Microlife Digital Infrared Ear Thermometer, Model IR1DN1 (IR210), and its substantial equivalence to a predicate device. Here's a breakdown of the acceptance criteria and the study details:
1. Table of Acceptance Criteria and Reported Device Performance
| Acceptance Criterion (Standard or Requirement) | Reported Device Performance (Compliance) |
|---|---|
| Measurement Range (Body Mode): 32.0-43.0 °C (89.6-109.4 °F) | Subject device achieved this range, wider than predicate. This did not introduce new risks. |
| Accuracy (Blackbody Mode): | Passed all testing requirements per ASTM E1965-98 and ISO 80601-2-56. |
| - ±0.2 °C: 35.0 ~ 42.0 °C | Achieved this accuracy. |
| - ±0.3 °C: 32.0 ~ 34.9 °C & 42.1 ~ 43.0 °C | Achieved this accuracy. |
| - ±0.4 °F: 95.0 ~ 107.6 °F | Achieved this accuracy. |
| - ±0.5 °F: 89.6 | Achieved this accuracy. |
| Biocompatibility (Measuring probe material - PCTG) | Tested per ISO 10993 standard; proven biocompatible. |
| Biocompatibility (Probe cover - Rigid PP) | Tested per ISO 10993 standard; proven biocompatible. Clinical study showed no effect on accuracy/performance. |
| Biocompatibility ("Start"/"Power" button material - PMMA) | Tested per ISO 10993 standard; proven biocompatible. |
| Position Indication Feature | Validated and verified through performance testing and clinical testing. |
| Integrated Circuitry (IC) Changes | Verified through performance testing. |
| General Safety and Essential Performance (AAMI/ANSI ES60601-1:2005/(R2012) and A1:2012, C1:2009/(R)2012 and A2:2010/(R2012)) | Passed all testing requirements. |
| Electromagnetic Compatibility (AAMI/ANSI/IEC 60601-1-2:2014) | Passed all testing requirements. |
| Infrared Thermometer Performance (ASTM E1965-98 (2016)) | Passed all testing requirements. |
| Risk Management (AAMI/ANS/ISO 14971:2007/(R)2010) | Passed all testing requirements; risk assessment conducted due to modifications. |
| Biological Evaluation (AAMI/ANSI/ISO 10993-1: 2009/(R)2013) | Passed all testing requirements. |
| Cytotoxicity (AAMI/ANSI/ISO 10993-5:2009/(R)2014) | Passed all testing requirements. |
| Irritation and Skin Sensitization (AAMI/ANSI/ISO 10993-10: 2010/(R)2014) | Passed all testing requirements. |
| Sample Preparation and Reference Materials (AAMI/ANSI/ISO 10993-12: 2012) | Passed all testing requirements. |
| Specific Requirements for Clinical Thermometers (ISO 80601-2-56: 2017) | Passed all testing requirements. |
| Requirements for Medical Electrical Equipment and Medical Electrical Systems in the Home Healthcare Environment (AAMI/ANSI HA60601-1-11:2015) | Passed all testing requirements. |
| Clinical Study Protocol Acceptance Criteria | Clinical data (clinical bias, uncertainty of bias, clinical repeatability) met these criteria. |
2. Sample Size Used for the Test Set and Data Provenance
- Sample Size: 114 subjects.
- Data Provenance: The study was a clinical investigation, implying prospective data collection specifically for this study. The location of the clinical study is not explicitly stated, but it's a "clinical investigation" and a "clinical study" was conducted.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts
The document does not specify the number or qualifications of experts used to establish ground truth. It states that "clinical data, represented by clinical bias, with uncertainty of bias, and clinical repeatability, met the acceptance criteria of the clinical study protocol," which implies a comparison against a reference standard or method for temperature measurement, likely managed by clinical professionals, but their specific roles, number, or qualifications are not detailed.
4. Adjudication Method for the Test Set
The document does not explicitly state an adjudication method (e.g., 2+1, 3+1). It describes the clinical study as a "randomization, simple blind homologous control, pairing design," but this refers to the study design rather than a reader adjudication process. For temperature measurement, ground truth is typically established by high-precision reference thermometers rather than expert consensus on interpretation.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was Done
No, a Multi-Reader Multi-Case (MRMC) comparative effectiveness study was not done. The device is a digital infrared ear thermometer, and its performance is evaluated directly against known temperature standards and clinical correlations, not through human reader interpretation.
6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) was Done
Yes, the performance testing described in the various standards (e.g., ASTM E1965-98, ISO 80601-2-56) and the accuracy in blackbody mode inherently represent standalone performance. The device provides a direct temperature reading. The clinical study then validated this standalone reading in a real-world setting.
7. The Type of Ground Truth Used
The ground truth for the device's accuracy is established through objective measurement against:
- Blackbody mode accuracy: For measuring the device's inherent precision against a controlled and known temperature source.
- Clinical Study Protocol: Which would involve comparing the device's readings to established clinical reference temperature measurement methods. The document mentions "clinical bias, with uncertainty of bias, and clinical repeatability," which are standard metrics for comparing a device to a reference measurement in a clinical setting.
8. The Sample Size for the Training Set
The document does not mention a training set or machine learning models. This device is a traditional electronic thermometer that uses an infrared sensor and an algorithm to convert infrared energy into a temperature value. It doesn't appear to use learning-based AI or require a training set in the conventional sense.
9. How the Ground Truth for the Training Set was Established
As no training set is indicated, this question is not applicable.
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which consists of the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG" in blue, with the word "ADMINISTRATION" underneath. The logo is simple and professional, and it is easily recognizable.
July 16, 2019
Microlife Intellectual Property GmbH % Susan D. Goldstein-Falk Official Correspondent for Microlife Intellectual Property GmbH mdi Consultants, Inc. 55 Northern Boulevard, Suite 200 Great Neck, New York 11021
Re: K183663
Trade/Device Name: Microlife Digital Infrared Ear Thermometer, Model IR1DN1 (IR210) Regulation Number: 21 CFR 880.2910 Regulation Name: Clinical Electronic Thermometer Regulatory Class: Class II Product Code: FLL Dated: June 14, 2019 Received: June 17, 2019
Dear Susan D. Goldstein-Falk:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal
{1}------------------------------------------------
statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
for Alan Stevens Assistant Director DHT3C: Division of Drug Delivery and General Hospital Devices, and Human Factors OHT3: Office of Gastrorenal, ObGyn, General Hospital and Urology Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
Indications for Use
510(k) Number (if known)
Device Name
Microlife Digital Infrared Ear Thermometer, Model IR 1DN1(IR210)
Indications for Use (Describe)
The Microlife Digital Infrared Ear Thermometer, Model IRIDNI (IR210) device is an electronic clinical thermometer using an infrared sensor to detect body temperature from the auditory canal in the neonatal, pediation used in the home setting.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| ------------------------------------------------- | -- |
Prescription Use (Part 21 CFR 801 Subpart D)
X Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{3}------------------------------------------------
510(k) SUMMARY
The assigned 510(k) number is K183663
| Manufacturer's Name: | Microlife Intellectual Property GmbH, SwitzerlandEspenstrasse 1399443 Widnau / Switzerland |
|---|---|
| Corresponding Official: | Mr. Gerhard FrickVice President of Technical and ServiceMicrolife Intellectual Property GmbH,Switzerland |
| Telephone Number: | +41 79 216 0070 |
| Email: | gerhard.frick@microlife.ch |
| Preparation Date: | June 26, 2019 |
| Trade Name: | Microlife Digital Infrared Ear Thermometer,Model IR1DN1 (IR210) |
| Common or Usual Name: | Clinical Electronic Thermometer |
| Regulation Name:Regulation Number:Product Code:Device Class:Primary Predicate Device: | Clinical Electronic Thermometer21 CFR 880.2910FLLClass IIK003308 Microlife Digital Infrared EarThermometer, Model IR1DB1 |
Device Description:
The Microlife Digital Infrared Ear Thermometer, Model IR1DN1 (IR210) is an electronic thermometer using an infrared sensor (thermopile) to detect body temperature from the auditory canal. Its operation is based on measuring the natural thermal radiation emanating from the tympanic membrane and the adjacent surfaces.
{4}------------------------------------------------
Mode of operation:
The unit measures the infrared energy emitting from the middle ear and the surrounding tissue. This energy is absorbed by lenses and converted into temperature values.
The Microlife Digital Infrared Ear thermometer, Model IR1DN1 (IR210), consists of the following parts:
- a) Thermopile Sensor
- b) Application-Specific Integrated Circuitry
- c) EEPROM IC
- d) Capacitance-touch IC
- e) LCD and Backlight
- f) 3 buttons ("START/POWER" button, "M" button, "MODE" button)
- g) 1 battery CR2032 3.0V
- h) Probe cover
- I) Lens
The new Model IR1DN1 (IR210) has the same intended use and temperature measurement fundamental algorithm as the predicate device 510(k) K#003308 Microlife Model IR1DB1.
Indications for Use
The Microlife Digital Infrared Ear Thermometer, Model IR1DN1 (IR210) device is an electronic clinical thermometer using an infrared sensor to detect body temperature from the auditory canal in the neonatal, pediatric and adult population used in the home setting.
Substantial Equivalence Discussion
Both subject device and predicate device use infrared technology to measure and monitor the body temperature by the site of ear canal.
Microlife Digital Infrared Ear Thermometer IR1DN1 (IR210) has been compared to the cleared "Microlife Digital Infrared Ear Thermometer IR1DB1" (510(k) K#003308). A table comparing the two devices is provided as follows:
{5}------------------------------------------------
| Item | 1. Subject DeviceMicrolife Digital Infrared EarThermometer IR1DN1(IR210)K183663 | 2. Predicate DeviceMicrolife Digital InfraredEar Thermometer IR1DB1K003308 | Comparison |
|---|---|---|---|
| Indications forUse | The Microlife Digital Infrared EarThermometer, Model IR1DN1(IR210) device is an electronicclinical thermometer using aninfrared sensor to detect bodytemperature from the auditorycanal in the neonatal, pediatricand adult population used in thehome setting. | The device is an electronicclinical thermometer usingan infrared sensor todetect body temperaturefrom the auditory canal inthe neonatal, pediatric andadult population used inthe home setting. | Same |
| Thermometertype | Infrared thermometer | Infrared thermometer | Same |
| DeviceMeasurementTechnology | Infrared | Infrared | Same |
| Measurementtarget | Human Ear | Human Ear | Same |
| Measuringlocation | Ear Canal | Ear Canal | Same |
| Physicaldimension | 159mm(L)*43mm(W)*60mm(H) | 128mm(L)*48mm(W)*30mm(H) | Different |
| Power supply | 3.0V DC with 1 CR2032 battery | 3.0V DC with 1 CR2032battery | Same |
| Displayresolution | 0.1°C or 0.1°F | 0.1°C or 0.1°F | Same |
| Item | 1. Subject DeviceMicrolife Digital Infrared EarThermometer IR1DN1(IR210)K183663 | 2. Predicate DeviceMicrolife Digital InfraredEar ThermometerIR1DB1,K003308 | Comparison1 vs 2 |
| Inspect theaccuracy ofblackbody | The sample must be pressed"Start" button for 8 secondswhen the unit turns off, after twoshort beep sounds, release"Start" button, enters theblackbody measurement mode.The unit display 0.01°C or0.01°F resolution in this mode. | The sample must bepressed "Start" button for 8seconds when the unit turnsoff, after two short beepsounds, release "Start"button, enters the blackbodymeasurement mode. Theunit display 0.01°C or0.01°F resolution in thismode. | Same |
| Measuringrange(bodymode) | 32.0-43.0 °C(89.6-109.4 °F) | 32.0°C | Different(1) See below |
| Accuracy(blackbody mode) | ±0.2 °C: 35.0 ~ 42.0 °C±0.3 °C: 32.0 ~ 34.9 °C& 42.1 ~ 43.0 °C±0.4 °F: 95.0 ~ 107.6 °F±0.5 °F: 89.6 | ±0.2ºC: 32.0 | Different(2) See below |
| Operatingconditions | 10°C | 10°C | Same |
| Storageconditions | -25°C ~ 55 °C/-13°F ~131°F15-95 % relative maximumhumidity | -25°C ~ 55 °C/-13°F ~131°F15-95 % relative maximumhumidity | Same |
| Display type | LCD display | LCD display | Same |
| Memory | 30 sets memories | One set memory | Different(3) See below |
| Error | Display $Er6$ ifsystem malfunction. | Display $Err$ ifsystemmalfunction. | Different(4) See below |
| Power auto offin clinical modeand blackbodymode | Approx. 1 minute after lastmeasurement has been taken | Approx. 1 minute after lastmeasurement has beentaken | Same |
| Item | 1. Subject DeviceMicrolife Digital Infrared EarThermometer IR1DN1(IR210)K183663 | 2. Predicate DeviceMicrolife Digital Infrared EarThermometerIR1DB1,K003308 | Comparison |
| 1 vs 2 | |||
| Sensor type | TPS23B | OTP-668D2 | Different(5) See below |
| Lens type | Transparent | Transparent | Same |
| High TemperatureAlarm | 10 short beeps and a red LCDbacklight alert the patient thathe/she may have a temperatureequal to or higher than 37.5 °C. | 10 short beeps and a redLCD backlight alert thepatient that he/she may havea temperature equal to orhigher than 37.5 °C. | Same |
| Measuring probematerial | PCTG(TX2001) | ABS707 | Different(6) See below |
| Probe cover | Rigid cover (PP) | Soft cover (PE) | Different(7) See below |
| Positioningindication | Yes | No | Different(8) See below |
| IC(IntegratedCircuitry) | HY11P14 | SN8P1919 | Different(9) See below |
| Offset | With | With | Same |
| Clinical StudySupport | Yes. Clinical test report | Yes. Clinical test report | Same |
| "Start "/ "Power"button material | PMMA | ABS707 | Different(10) See below |
| Housing andbattery covermaterial | ABS707 | ABS707 | Same |
| Patient contact Materials | |||
| Probe Cover | Rigid cover(Polypropylene (PP)) | Soft cover(Polyethylene (PE)) | Different(7) See below |
| Measuring probe material | PCTG(TX2001) | ABS707 | Different(6) See below |
| "Start"/ "Power" buttonmaterial | PMMA | ABS707 | Different(10) See below |
| Housing and battery covermaterial | ABS707 | ABS707 | Same |
{6}------------------------------------------------
{7}------------------------------------------------
{8}------------------------------------------------
The major differences between the subject modified device IR1DN1 (IR210), and the predicate device IR1DB 1 are the measurement range, probe cover, position indicator, measuring probe and buttons material.
The Indications for Use statement of the subject device is identical to the predicate device. Other differences between the devices are:
1. Measurement range (body mode)
The subject device IR1DN1 (IR210) body mode measurement range is 32.0-43.0 ℃ (89.6-109.4 °F), whereas the predicate device IR1DB1 measurement range is 32.0°C ~42.2°C (89.6 ~108.0 °F). The subject device has a wider body mode measurement range to accommodate more physiologically relevant temperatures. This does not introduce any new risk to the device.
2. Accuracy (blackbody mode)
The modified device's accuracy: ±0.2 °C: 35.0 ~ 42.0 °C, ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------±0.4°F:95.0107.6 °F ±0.5°F:89.694.8°F&107.8~109.4 °F
The predicate device's accuracy: ±0.2°C: 32.042.2°C, ±0.4°F, 89.6108.0°F.
The modified device's measurement range and accuracy are wider than the predicate device. ; these are based on device's performance standards and patient's requirement. These differences do not affect the performance and accuracy according to our Reliability Test Report (ASTM E1965- 98), ISO 80601-2-56 Test Report, and our Clinical Test Report of IR1DN1 (IR210).
{9}------------------------------------------------
3. Memory
The modified device IR1DN1 (IR210) can recall the last 30 readings, whereas the predicate device IR1DB1 can only recall the last reading. Only storage reading quantity is different which does not affect the device's performance or safety and effectiveness.
4. Error
Both modified device IR1DN1 (IR210) and the predicate device IR1DB1 have self-test function. The principle of self-test is the same. Devices can perform a self-test every time when it is switched on to always guarantee the specified accuracy of any measurement, when it has error, it will display signal. IR1DN1 (IR210) device will display icon "Er6", IR1DB1 will display icon "Err". Although the icons are different, the purpose is the same. This does not affect the device's performance or safety and effectiveness.
5. Sensor Type
The sensor type of the modified device is TPS23B, whereas the sensor type of the predicate device is OTP-668D2. The difference does not affect the performance and accuracy according to Reliability Test Report (ASTM E1965-98), ISO 80601-2-56 Test Report and Clinical Test Report of IR1DN1 (IR210).
6. Measuring probe material
The measuring probe material of the subject device is PCTG, whereas the measuring probe material of the predicate device is ABS707. The probe is not the patient contacting material. Biocompatibility testing was performed on the PCTG material in accordance with ISO 10993 standard and testing results proved the subject probe material to be biocompatible.
7. Probe cover
The subject device measures with rigid cover (PP), whereas the predicate device measures with a soft cover (PE). Biocompatibility testing was performed on the finished subject probe cover according to the ISO10993 standard. Our Biocompatibility Test Report of the PP material (Rigid Probe Cover) proves the subject probe cover material to be biocompatible. Our Clinical Test Report of IR1DN1 (IR210), showed that the subject probe cover did not affect the subject modified device's accuracy and performance.
8. Position indication
The subject device includes a position indication feature which was not included with the predicate device. This feature has been validated and verified through performance testing and clinical testing.
{10}------------------------------------------------
9. IC (Integrated Circuitry)
The integrated circuit model and its features have changes have been verified through performance testing.
10. "Start"/ "Power" button
The button material of the subject device is PMMA, whereas the button material of the predicate device is ABS707. The PMMA material's biocompatibility testing was performed according to ISO10993 standard. Biocompatibility Test Report of PMMA testing proved that the subject button material to be biocompatible.
Based on the aforementioned modifications to the subject device, the subject device does not raise different types of safety and effectiveness questions when compared to the predicate device.
Performance Testing
Testing information demonstrating performance of the Microlife Digital Infrared Ear Thermometer, Model IR1DN1 (IR210) in the intended environment of use is supported by testing that was conducted in accordance with Guidance on the Content of Premarket Notification [510(K)] Submissions for Clinical Electronic Thermometers.
The following testing was conducted to prove safety and effectiveness as well as substantial equivalence to the predicate devices:
| 1 | AAMI/ANSI ES60601-1:2005/(R2012) and A1:2012,C1:2009/(R)2012 andA2:2010/(R2012) | Passed all testing requirements |
|---|---|---|
| 2 | AAMI/ANSI/IEC 60601-1-2:2014 | Passed all testing requirements |
| 3 | ASTM E1965-98 (2016) | Passed all testing requirements |
| 4 | AAMI/ANS/ISO 14971:2007/(R)2010 | Passed all testing requirements |
| 5 | AAMI/ANSI/ISO 10993-1: 2009/(R)2013 | Passed all testing requirements |
| 6 | AAMI/ANSI/ISO 10993-5:2009/(R)2014 | Passed all testing requirements |
| 7 | AAMI/ANSI/ISO 10993-10: 2010/(R)2014 | Passed all testing requirements |
| 8 | AAMI/ANSI/ISO 10993-12: 2012 | Passed all testing requirements |
| 9 | ISO 80601-2-56: 2017 | Passed all testing requirements |
| 10 | AAMI/ANSI HA60601-1-11:2015 | Passed all testing requirements |
{11}------------------------------------------------
Performance Testing Summary
A risk assessment was conducted in accordance is ISO 14971:2007/EN ISO 14971:2012 to assess risk management activities due to modifications to our predicate device. Verification activities that were performed included modifications, associated risk, validation method, and results revealed that all acceptance criteria passed.
Clinical Tests Conducted
Clinical testing was conducted according to ASTM E1965-98 and ISO 80601-2-56. This clinical study is a randomization, simple blind homologous control, pairing design of clinical investigation, consists of 114 subjects, of which 1/3 are infants, 1/3 are children and the rest 1/3 are adults (NOTE: Infants---newborn to one year: Children--- greater than one to five years; Adults---greater than five years old.). The test reports demonstrated that the clinical data, represented by clinical bias, with uncertainty of bias, and clinical repeatability, met the acceptance criteria of the clinical study protocol.
Conclusions
Based on the performance testing, comparison, analysis, and risk assessment, it demonstrated that the Microlife Digital Infrared Ear Thermometer IR1DN1 (IR210) is substantially equivalent to the Microlife Digital Infrared Ear Thermometer IR1DB1, cleared under K003308.
§ 880.2910 Clinical electronic thermometer.
(a)
Identification. A clinical electronic thermometer is a device used to measure the body temperature of a patient by means of a transducer coupled with an electronic signal amplification, conditioning, and display unit. The transducer may be in a detachable probe with or without a disposable cover.(b)
Classification. Class II (performance standards). The device is exempt from the premarket notification procedures in part 807, subpart E of this chapter, subject to the limitations in § 880.9 and the following conditions for exemption:(1) Device is not a clinical thermometer with telethermographic functions;
(2) Device is not a clinical thermometer with continuous temperature measurement functions; and
(3) Appropriate analysis and testing (such as that outlined in the currently FDA-recognized editions, as appropriate, of ISO 80601-2-56, “Medical electrical equipment—Part 2-56: Particular requirements for basic safety and essential performance of clinical thermometers for body temperature measurement,” or ASTM E1965, “Standard Specification for Infrared Thermometers for Intermittent Determination of Patient Temperature,” or ASTM E1112, “Standard Specification for Electronic Thermometer for Intermittent Determination of Patient Temperature,” or ASTM E1104, “Standard Specification for Clinical Thermometer Probe Covers and Sheaths”) must validate specifications and performance of the device.